Type 1 diabetes is a serious, lifelong condition that requires constant management and carries real risks to long-term health. On average, people with type 1 diabetes live about 11 fewer years than people without diabetes, with men averaging 65 years and women about 68 years compared to roughly 80 and 84 years respectively. Those numbers are improving with modern care, but they reflect a disease that affects nearly every system in the body when blood sugar isn’t well controlled.
Why Type 1 Diabetes Is Different
In type 1 diabetes, the immune system destroys the cells in the pancreas that produce insulin. Without insulin, sugar builds up in the blood and the body’s cells starve for energy. There is no way to prevent it, no way to reverse it, and no pill that treats it. Every person with type 1 diabetes depends on injected or pumped insulin to survive, every single day, for the rest of their life.
This is fundamentally different from type 2 diabetes, where the body still makes insulin but doesn’t use it efficiently. Type 2 can sometimes be managed with lifestyle changes or oral medications. Type 1 cannot. Despite the old name “juvenile diabetes,” it can develop at any age. Peak diagnosis occurs in children between ages 4 and 7 and again between 10 and 14, but adults are diagnosed too.
The Immediate Danger: Diabetic Ketoacidosis
The most acute threat in type 1 diabetes is diabetic ketoacidosis, or DKA. When the body has too little insulin, it starts breaking down fat for fuel and produces acidic byproducts called ketones. Left untreated, DKA causes organ failure and death. It can develop in hours, especially during illness, insulin pump malfunctions, or missed doses. DKA is sometimes the very first sign that someone has type 1 diabetes, sending them to the emergency room before they even know they have the condition.
Hospital fatality rates for DKA have dropped significantly over the past two decades, falling from 1.1% to 0.4%. That’s good news, but it still means DKA kills people, and hospitalization rates have actually been rising among younger adults with established diabetes who struggle to maintain consistent blood sugar control.
Low Blood Sugar Is an Ongoing Risk
While high blood sugar causes long-term damage, low blood sugar (hypoglycemia) is the more immediate daily threat. It happens when too much insulin, too little food, or unexpected exercise drops blood sugar below safe levels. Mild episodes cause shakiness, confusion, and sweating. Severe episodes can cause seizures, loss of consciousness, and death.
Severe hypoglycemia is not rare. Studies show that roughly 35 to 40% of people with type 1 diabetes experience at least one severe episode over a six-month period, meaning an event so serious they need someone else’s help to recover. About 11% lose consciousness. These episodes can happen during sleep, while driving, or at work, making them dangerous not just medically but practically.
Long-Term Complications
Years of elevated blood sugar damages blood vessels throughout the body. The consequences touch nearly every organ:
- Heart and blood vessels. People with type 1 diabetes are about 10 times more likely to develop cardiovascular disease than people without it, according to the American Heart Association. Heart attack and stroke are the leading causes of death in this population.
- Kidneys. Damaged blood vessels in the kidneys can lead to kidney failure requiring dialysis or transplant.
- Eyes. Damage to the tiny blood vessels in the retina causes diabetic retinopathy, a leading cause of blindness in working-age adults.
- Nerves. Nerve damage, particularly in the feet and legs, causes pain, numbness, and in severe cases contributes to amputations.
None of these complications are inevitable. Keeping blood sugar closer to normal dramatically reduces the risk of all of them. But “keeping blood sugar closer to normal” is far easier to say than to do, which brings up the daily reality of living with this disease.
The Weight of Daily Management
Managing type 1 diabetes is essentially a full-time job layered on top of everything else in a person’s life. Research estimates that people with type 1 diabetes make between 180 and 300 decisions about their medical care every day. That includes calculating carbohydrates in every meal and snack, deciding how much insulin to take, adjusting for exercise, accounting for stress or illness, checking blood sugar levels multiple times, and responding to readings that are too high or too low.
There is no autopilot. Insulin needs change based on activity level, hormones, sleep quality, weather, and dozens of other variables. A meal that requires a certain dose one day might need a completely different dose the next. Getting it wrong in one direction causes dangerously low blood sugar within minutes. Getting it wrong in the other direction causes high blood sugar that, repeated over years, leads to the complications described above.
This relentless decision-making takes a measurable toll on mental health. Diabetes distress and burnout are common, and rates of depression and anxiety are significantly higher in people with type 1 diabetes than in the general population.
The Financial Cost
Type 1 diabetes is expensive. A 2018 study of over 65,000 privately insured patients found that out-of-pocket costs averaged about $2,500 per year, with families of children spending the most on supplies (averaging $823 annually for pediatric patients versus $445 for adults). Eight percent of patients spent more than $5,000 out of pocket. These figures cover only the patient’s share and don’t include what insurance pays, which is substantially more. Insulin, continuous glucose monitors, pump supplies, test strips, and regular doctor visits all add up, and the costs are lifelong.
How Modern Tools Are Changing the Picture
The seriousness of type 1 diabetes hasn’t changed, but the tools for managing it have improved enormously. Continuous glucose monitors provide real-time blood sugar readings every few minutes, alerting users to dangerous highs and lows before they become emergencies. Automated insulin delivery systems, sometimes called “artificial pancreas” technology, pair these monitors with insulin pumps that adjust delivery automatically.
These technologies help reduce the time spent in dangerous blood sugar ranges and ease some of the decision-making burden. People who use them consistently tend to have better blood sugar control, fewer hypoglycemic emergencies, and lower rates of DKA. The life expectancy gap has been narrowing over the past several decades, and better technology is one reason.
Still, these tools require consistent attention and access. They malfunction, they need calibration, and they cost money. They make management more effective, not effortless. Type 1 diabetes remains a condition where the person living with it is their own life-support system, making hundreds of small medical decisions daily to stay alive and healthy.